EUVIMEDEUVIMED entdecken
Crossref

Quality of Life and Potential Biomarkers in Different Phenotypes of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Mauricio López-Chacón, María J Rojas-Lechuga, Marina Bantulà, Maria Barros, Cristóbal Langdon, Concepció Marín, Joaquim Mullol, Isam Alobid

Journal of Investigational Allergology and Clinical Immunology · 10.03.2026 · 36 (6)

DOI: 10.18176/jiaci.1132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigational Allergology and Clinical Immunology, online erschienen am 10.03.2026. Verfasst von Mauricio López-Chacón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Skull Base Unit, ENT Department, Hospital Clinic Barcelona, Barcelona, Catalonia, Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic rhinosinusitis with nasal polyps (CRSwNP) significantly impairs quality of life (QOL), especially in individuals with comorbid asthma and nonsteroidal anti-inflammatory drug–exacerbated respiratory disease (N-ERD). The 22-item Sino-Nasal Outcome Test (SNOT-22) is a validated questionnaire for assessing QOL in these patients.

Objectives

To evaluate the subjective burden of CRSwNP, CRSwNP with asthma, and N-ERD using SNOT-22 and investigate associations with serum chemokines and cytokines as biomarkers in a representative sample of individuals from the 3 phenotypes. Material and Methods: This cross-sectional study analyzed data from 117 participants in the rhinology unit between 2015 and 2021. Symptoms and disease severity were evaluated (mean [SD]) using the visual analog scales (VAS), SNOT-22, Lund-Mackay score (LMS), nasal polyp score (NPS), and aeroallergen sensitization test (atopy). Serum levels of 17 cytokines and chemokines were measured using Luminex/ELISA.

Results

The SNOT-22 (56.3 [22.5]), LMS (19.2 [4.9]), and NPS (5.3 [1.4]) scores were worse for the N-ERD phenotype than for CRSwNP with and without asthma. This group was the most affected in sinonasal severity VAS scores (P

Schlagwörter

Stichwörter der Autor:innen

AsthmaBiomarkersChronic rhinosinusitis with nasal polypsN-ERDNPSQuality of lifeSNOT-22VAS

Autor:innen und Institutionen

  • Skull Base Unit, ENT Department, Hospital Clinic Barcelona, Barcelona, Catalonia, Spain.
  • INGENIO, IRCE, Institut d´Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
  • CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III.
  • Rhinology Unit & Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Catalonia, Spain.
  • Department of Medicine, Faculty of Medicine and Health Sciences, Universitat de Barcelona (UB), Barcelona, Spain.

Zitieren

APA

López-Chacón, M., Rojas-Lechuga, M. J., Bantulà, M., Barros, M., Langdon, C., Marín, C., Mullol, J., & Alobid, I. (2026). Quality of Life and Potential Biomarkers in Different Phenotypes of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP). Journal of Investigational Allergology and Clinical Immunology, 36(6). https://doi.org/10.18176/jiaci.1132

Vancouver

López-Chacón M, Rojas-Lechuga MJ, Bantulà M, Barros M, Langdon C, Marín C, et al. Quality of Life and Potential Biomarkers in Different Phenotypes of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP). Journal of Investigational Allergology and Clinical Immunology. 2026;36(6). doi:10.18176/jiaci.1132

BibTeX
@article{LpezChacn2026,
  author = {López-Chacón, Mauricio and Rojas-Lechuga, María J and Bantulà, Marina and Barros, Maria and Langdon, Cristóbal and Marín, Concepció and Mullol, Joaquim and Alobid, Isam},
  title = {Quality of Life and Potential Biomarkers in Different Phenotypes of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)},
  journal = {Journal of Investigational Allergology and Clinical Immunology},
  year = {2026},
  volume = {36},
  number = {6},
  doi = {10.18176/jiaci.1132}
}
Kostenlos starten →